Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder
Related coverage: Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder Fierce Pharma
Aug 19, 2026
Publisher
Fierce Pharma News
The latest headlines and summaries aggregated from Fierce Pharma on AIMode News.
3 recent stories from Fierce Pharma
Advertisement
Advertisement
Health
Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder
Related coverage: Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder Fierce Pharma
Health
Celcuity keeps cool amid questions about Revtorpyk launch timing
Related coverage: Celcuity keeps cool amid questions about Revtorpyk launch timing Fierce Pharma
Health
Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio
Related coverage: Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio Fierce Pharma